Directory
>
Benjamin Brod
Benjamin Brod
Chief Commercial Transactions Officer | Agenus
New York, New York, United States
Benjamin Brod
Summary
Benjamin Brod is a seasoned legal professional with extensive experience in corporate governance and transactional law. Currently serving as the Chief Commercial Transactions Officer at Agenus, he has a strong background in managing complex legal matters in both pharmaceutical and legal services industries. His previous roles at Novartis included Global Head Legal for Oncology BD&L and Senior Legal Counsel for M&A, showcasing his expertise in mergers and acquisitions. Benjamin's education from prestigious institutions such as New York University School of Law and Duke University has laid a solid foundation for his legal acumen. He has a proven track record of advising clients on regulatory compliance and corporate transactions. Beyond his legal expertise, he is known for his strategic thinking and ability to lead diverse teams in high-pressure environments. His passion for corporate law is complemented by a commitment to fostering ethical business practices. Benjamin's multifaceted background positions him as a key player in navigating the complexities of commercial transactions.
Benjamin Brod
Work Experience
Chief Commercial Transactions Officer at
Agenus
March 2023 - Present
Global Head Legal, Oncology BD&L and Portfolio Management at
Novartis
February 2020 - January 2023
Executive Director - Senior Counsel at
Novartis
September 2018 - February 2020
Senior Legal Counsel M&A at
Novartis
September 2014 - August 2018
M&A Associate at
A&O Shearman
February 2010 - August 2014
Benjamin Brod
Education
New York University School of Law, Doctor Of Law (Jd)
January 2006 - January 2009
Duke University, Ab
January 2000 - January 2004
Frequently Asked Questions about Benjamin Brod
What is Benjamin Brod email address?
Benjamin Brod's primary email address is *************@novartis.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Benjamin Brod work for?
Benjamin Brod is a Chief Commercial Transactions Officer at Agenus, a company specializing in Commercial physical research.
Where Benjamin Brod graduated from?
Benjamin Brod holds a degree in from New York University School of Law.
How can I directly contact Benjamin Brod?
To contact Benjamin Brod directly, you can use the email address *************@novartis.com. Complete contact information is available upon registration with Muraena.
Who is Benjamin Brod?
Benjamin Brod is a seasoned legal professional with extensive experience in corporate governance and transactional law. Currently serving as the Chief Commercial Transactions Officer at Agenus, he has a strong background in managing complex legal matters in both pharmaceutical and legal services industries. His previous roles at Novartis included Global Head Legal for Oncology BD&L and Senior Legal Counsel for M&A, showcasing his expertise in mergers and acquisitions. Benjamin's education from prestigious institutions such as New York University School of Law and Duke University has laid a solid foundation for his legal acumen. He has a proven track record of advising clients on regulatory compliance and corporate transactions. Beyond his legal expertise, he is known for his strategic thinking and ability to lead diverse teams in high-pressure environments. His passion for corporate law is complemented by a commitment to fostering ethical business practices. Benjamin's multifaceted background positions him as a key player in navigating the complexities of commercial transactions.
Benjamin`s contact details
*************@novartis.com
*************@agenusbio.com
Colleagues
Independent board member
Chief Commercial Officer
Vice President, Commercial Operations and Business Analytics
Vice President, Technical Operations
Chief Medical Officer
Chief Quality Officer
Executive Director, Global Financial Operations
Associate Vice President, Head of Global HEOR Medical Value Access
VP Molecular and Information Science
Vice President, Research